Related Experiment Video
Updated: Jun 5, 2026
06:09
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
Lymphangiogenesis and cancer metastasis
Mahir A A Al-Rawi1, Wen G Jiang
1Department of Surgery, Betsi Cadwaladr University Health Board Glan Clwyd Hospital, Rhyl, Denbighshire LL18 5UJ, UK. mahir.al-rawi@doctors.org.uk
Frontiers in Bioscience (Landmark Edition)
|January 4, 2011
Summary
Lymphangiogenesis, the formation of lymphatic vessels, is vital for tissue development and cancer metastasis. Targeting this process may offer new strategies to combat tumor spread in various human cancers.
Area of Science:
- Biomedical Science
- Molecular Biology
- Oncology
Background:
- Lymphangiogenesis is critical for normal tissue development and lymphatic diseases.
- Understanding lymphatic system development offers insights into pathological processes like cancer metastasis.
- Tumor lymphatic metastasis to regional lymph nodes is an early, prognostic indicator in many solid tumors.
Purpose of the Study:
- To review the development and regulation of the lymphatic system.
- To explore the role of lymphangiogenesis in human cancers.
- To discuss the potential of targeting lymphangiogenesis for cancer therapy.
Main Methods:
- Literature review of lymphatic system development.
- Analysis of lymphangiogenesis regulation.
- Exploration of the link between lymphangiogenesis and human cancers.
Main Results:
- The lymphatic system develops through complex regulatory mechanisms.
- Lymphangiogenesis is implicated in tumor cell metastasis to lymph nodes.
- Many human solid tumors are lymphangiogenic, inducing their own lymphatic vessels.
Conclusions:
- Targeting lymphangiogenesis presents a novel therapeutic approach to prevent lymphatic cancer progression.
- Further research into anti-lymphangiogenic agents is warranted.
- The review highlights the dual role of lymphangiogenesis in health and disease.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...